Drug Trial Radar · NCT06958536
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
99
Planned (sponsor's estimate)
Start
Jun 3, 2025
Primary completion
Dec 17, 2026
Study completion Oct 17, 2029
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- May 6, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2, randomized, double-blind, 3-arm study for the treatment of Crohn's disease. The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared with placebo in participants with moderate to severe Crohn's disease. The total study duration is up to 168 weeks, with a treatment period of up to 158 weeks including an open-label (OL) long-term extension (LTE) period of up to 104 weeks for eligible participants.
Conditions
- Crohn's Disease
Interventions
brivekimigDrug
Route of Administration: Subcutaneous
PlaceboDrug
Route of Administration: Subcutaneous
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of participants who achieve endoscopic response at Week 16Time frame: From Baseline to Week 16
Locations
78 sites in 12 countries. Site status is shown where the registry gives one.
Investigational Site Number: 8400026
Fairhope, Alabama · Recruiting
Investigational Site Number: 8400024
Tucson, Arizona · Recruiting
Investigational Site Number: 8400005
Escondido, California · Recruiting
Investigational Site Number: 8400001
Lancaster, California · Recruiting
Investigational Site Number: 8400029
San Diego, California · Recruiting
Investigational Site Number: 8400032
Colorado Springs, Colorado · Recruiting
Investigational Site Number: 8400017
Kissimmee, Florida · Recruiting
Investigational Site Number: 8400015
Lighthouse PT, Florida · Recruiting
Investigational Site Number 8400028
Miami, Florida · Recruiting
Investigational Site Number: 8400012
Miami, Florida · Recruiting
Investigational Site Number: 8400007
Orlando, Florida · Recruiting
Investigational Site Number: 8400011
Palmetto Bay, Florida · Recruiting
Investigational Site Number: 8400019
Marietta, Georgia · Recruiting
Investigational Site Number: 8400025
Iowa City, Iowa · Recruiting
Investigational Site Number: 8400006
Kansas City, Kansas · Recruiting
Investigational Site Number: 8400022
Boston, Massachusetts · Recruiting
Investigational Site Number: 8400008
Wyoming, Michigan · Recruiting
Investigational Site Number: 8400013
St Louis, Missouri · Recruiting
Investigational Site Number: 8400003
Chapel Hill, North Carolina · Withdrawn
Investigational Site Number: 8400009
Harrisburg, Pennsylvania · Recruiting
Investigational Site Number: 8400002
Fredericksburg, Texas · Recruiting
Investigational Site Number: 8400010
Houston, Texas · Recruiting
Investigational Site Number: 8400016
Ogden, Utah · Recruiting
Investigational Site Number: 8400027
Richmond, Virginia · Withdrawn
Investigational Site Number: 0360001
Footscray, Australia · Recruiting
Investigational Site Number: 0360002
Brisbane, Queensland, Australia · Recruiting
Investigational Site Number: 0360004
Kurralta Park, South Australia, Australia · Recruiting
Investigational Site Number: 0560001
Leuven, Belgium · Recruiting
Investigational Site Number: 1560003
Changsha, China · Recruiting
Investigational Site Number: 1560008
Changsha, China · Recruiting
Investigational Site Number: 1560005
Changzhou, China · Recruiting
Investigational Site Number: 1560001
Guangzhou, China · Recruiting
Investigational Site Number: 1560006
Hangzhou, China · Recruiting
Investigational Site Number: 1560004
Nanchang, China · Recruiting
Investigational Site Number: 1560002
Shanghai, China · Recruiting
Investigational Site Number: 1560007
Shenyang, China · Recruiting
Investigational Site Number: 2030003
Hradec Králové, Czechia · Recruiting
Investigational Site Number: 2030005
Slaný, Czechia · Withdrawn
Investigational Site Number: 2030002
Brno, JM, Czechia · Recruiting
Investigational Site Number: 2500001
Montpellier, France · Recruiting
Showing 40 of 78 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.